Impact of Reduced Kidney Function on Cardiopulmonary Fitness in Patients with Systolic Heart Failure

Background: Decreased renal function has been consistently associated with increased mortality among patients with systolic heart failure. The relationship between estimated glomerular filtration rate (eGFR) and other high-risk features including reduced cardiorespiratory fitness has not been previously reported in this patient population. Methods: The HF-ACTION trial was a prospective, randomized trial of exercise therapy versus usual care in patients with systolic heart failure. Patients with class 2–4 heart failure and a left ventricular ejection fraction of ≤35% were recruited. Serum creatinine was measured up to 1 year prior to entry. The 4-variable modified Modification of Diet in Renal Disease equation was used to calculate eGFR. Peak oxygen consumption (peak VO2) was directly measured using gas exchange analysis during progressive exercise testing to volitional fatigue or adverse signs/symptoms. Results: Of 2,091 subjects (mean age 59 ± 13 years, with serum creatinine available at baseline), 72% were men, and 61, 33, and 5% were Caucasians, African Americans, and others, respectively. Older age, diabetes, and hypertension were all more frequent with declining eGFR. The Pearson correlation between eGFR and peak VO2 was 0.22 (p < 0.0001). Age was negatively correlated with both eGFR (r = –0.44, p < 0.0001) and peak VO2 (r = –0.27, p < 0.0001). The peak VO2 tended to decline across decreasing levels of eGFR. Individuals with an eGFR <30 ml/min/1.73 m2 had, on average, 2.1 high-risk features including peak VO2 <14 ml/kg/min, age >75 years, diabetes, and functional class 3–4 symptoms. Conversely, those with an eGFR >90 ml/min/1.73 m2 had relatively few (1.0) high-risk characteristics. Conclusions: Reduced renal filtration is associated with impaired cardiorespiratory fitness and a clustering of high-risk features in systolic heart failure patients which portend a more complicated course and higher all-cause mortality.

[1]  K. Kalantar-Zadeh,et al.  Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease , 2009, Nephrology.

[2]  B. Franklin,et al.  Renal dysfunction and acceleration of coronary disease , 2004, Heart.

[3]  W. Kraus,et al.  Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). , 2008, The American journal of cardiology.

[4]  J. Halter,et al.  Prediction, progression, and outcomes of chronic kidney disease in older adults. , 2009, Journal of the American Society of Nephrology : JASN.

[5]  R. Koerfer,et al.  Vitamin D insufficiency in congestive heart failure: Why and what to do about it? , 2006, Heart Failure Reviews.

[6]  M. Fisher,et al.  Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. , 2005, Journal of the American College of Cardiology.

[7]  Harlan M Krumholz,et al.  Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.

[8]  C. Lavie,et al.  Impact of obesity on the risk of heart failure and its prognosis. , 2008, Journal of the cardiometabolic syndrome.

[9]  L. Stevens,et al.  Testing for chronic kidney disease: a position statement from the National Kidney Foundation. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  John A Spertus,et al.  Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. , 2002, Journal of the American College of Cardiology.

[11]  Yang Qiu,et al.  CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  Neil R. Powe,et al.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. , 2007, Kidney international.

[13]  E. Heath Borg's Perceived Exertion and Pain Scales , 1998 .

[14]  S. Bhandari,et al.  Cellular basis of uraemic cardiomyopathy: a role for erythropoietin? , 2009, European journal of heart failure.

[15]  B. Franklin,et al.  Impact of obesity on cardiovascular disease. , 2011, The Medical clinics of North America.

[16]  Keith C. Norris,et al.  Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative , 2009, European heart journal.

[18]  Peter Stenvinkel,et al.  Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[19]  B. Kestenbaum,et al.  Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. , 2009, Atherosclerosis.

[20]  V. Fuster,et al.  Cardiovascular risk factors in patients with chronic kidney disease , 2009, Nature Reviews Cardiology.

[21]  J. Bereiter-Hahn,et al.  Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro. , 1997, Experimental nephrology.

[22]  P. McCullough Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? , 2003, Journal of the American College of Cardiology.

[23]  B. Franklin Survival of the fittest: evidence for high-risk and cardioprotective fitness levels. , 2002, Current sports medicine reports.

[24]  R. Casaburi,et al.  Metabolic acidosis during exercise in patients with chronic obstructive pulmonary disease. Use of the V-slope method for anaerobic threshold determination. , 1988, Chest.

[25]  W. Kraus,et al.  Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. , 2007, American heart journal.

[26]  N. Powe,et al.  World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.

[27]  A. Burger,et al.  Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. , 2004, The American journal of cardiology.

[28]  W. Kraus,et al.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.

[29]  B. Whipp,et al.  A new method for detecting anaerobic threshold by gas exchange. , 1986, Journal of applied physiology.